BMP2 Regulation of CXCL12 Cellular, Temporal, and Spatial Expression is Essential during Fracture Repair

Timothy J. Myers, Lara Longobardi, Helen Willcockson, Joseph D. Temple, Lidia Tagliafierro, Ping Ye, Tieshi Li, Alessandra Esposito, Billie M. Moats-Staats, Anna Spagnoli

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The cellular and humoral responses that orchestrate fracture healing are still elusive. Here we report that bone morphogenic protein 2 (BMP2)-dependent fracture healing occurs through a tight control of chemokine C-X-C motif-ligand-12 (CXCL12) cellular, spatial, and temporal expression. We found that the fracture repair process elicited an early site-specific response of CXCL12+-BMP2+ endosteal cells and osteocytes that was not present in unfractured bones and gradually decreased as healing progressed. Absence of a full complement of BMP2 in mesenchyme osteoprogenitors (BMP2cKO/+) prevented healing and led to a dysregulated temporal and cellular upregulation of CXCL12 expression associated with a deranged angiogenic response. Healing was rescued when BMP2cKO/+ mice were systemically treated with AMD3100, an antagonist of CXCR4 and agonist for CXCR7 both receptors for CXCL12. We further found that mesenchymal stromal cells (MSCs), capable of delivering BMP2 at the endosteal site, restored fracture healing when transplanted into BMP2cKO/+ mice by rectifying the CXCL12 expression pattern. Our in vitro studies showed that in isolated endosteal cells, BMP2, while inducing osteoblastic differentiation, stimulated expression of pericyte markers that was coupled with a decrease in CXCL12. Furthermore, in isolated BMP2cKO/cKO endosteal cells, high expression levels of CXCL12 inhibited osteoblastic differentiation that was restored by AMD3100 treatment or coculture with BMP2-expressing MSCs that led to an upregulation of pericyte markers while decreasing platelet endothelial cell adhesion molecule (PECAM). Taken together, our studies show that following fracture, a CXCL12+-BMP2+ perivascular cell population is recruited along the endosteum, then a timely increase of BMP2 leads to downregulation of CXCL12 that is essential to determine the fate of the CXCL12+-BMP2+ to osteogenesis while departing their supportive role to angiogenesis. Our findings have far-reaching implications for understanding mechanisms regulating the selective recruitment of distinct cells into the repairing niches and the development of novel pharmacological (by targeting BMP2/CXCL12) and cellular (MSCs, endosteal cells) interventions to promote fracture healing.

Original languageEnglish (US)
Pages (from-to)2014-2027
Number of pages14
JournalJournal of Bone and Mineral Research
Volume30
Issue number11
DOIs
StatePublished - Nov 2015

Fingerprint

Ligands
Bone and Bones
Fracture Healing
Proteins
Mesenchymal Stromal Cells
Pericytes
Up-Regulation
Chemokine CXCL12
Osteocytes
Cell Adhesion Molecules
Mesoderm
Coculture Techniques
Protein C
Osteogenesis
Blood Platelets
Down-Regulation
Endothelial Cells
Pharmacology
Population

Keywords

  • BMP2
  • CXCL12
  • ENDOSTEAL CELLS
  • FRACTURE REPAIR
  • MESENCHYMAL STROMAL CELLS

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine

Cite this

BMP2 Regulation of CXCL12 Cellular, Temporal, and Spatial Expression is Essential during Fracture Repair. / Myers, Timothy J.; Longobardi, Lara; Willcockson, Helen; Temple, Joseph D.; Tagliafierro, Lidia; Ye, Ping; Li, Tieshi; Esposito, Alessandra; Moats-Staats, Billie M.; Spagnoli, Anna.

In: Journal of Bone and Mineral Research, Vol. 30, No. 11, 11.2015, p. 2014-2027.

Research output: Contribution to journalArticle

Myers, TJ, Longobardi, L, Willcockson, H, Temple, JD, Tagliafierro, L, Ye, P, Li, T, Esposito, A, Moats-Staats, BM & Spagnoli, A 2015, 'BMP2 Regulation of CXCL12 Cellular, Temporal, and Spatial Expression is Essential during Fracture Repair', Journal of Bone and Mineral Research, vol. 30, no. 11, pp. 2014-2027. https://doi.org/10.1002/jbmr.2548
Myers, Timothy J. ; Longobardi, Lara ; Willcockson, Helen ; Temple, Joseph D. ; Tagliafierro, Lidia ; Ye, Ping ; Li, Tieshi ; Esposito, Alessandra ; Moats-Staats, Billie M. ; Spagnoli, Anna. / BMP2 Regulation of CXCL12 Cellular, Temporal, and Spatial Expression is Essential during Fracture Repair. In: Journal of Bone and Mineral Research. 2015 ; Vol. 30, No. 11. pp. 2014-2027.
@article{f9042d336b6843c09e8345573e0536d2,
title = "BMP2 Regulation of CXCL12 Cellular, Temporal, and Spatial Expression is Essential during Fracture Repair",
abstract = "The cellular and humoral responses that orchestrate fracture healing are still elusive. Here we report that bone morphogenic protein 2 (BMP2)-dependent fracture healing occurs through a tight control of chemokine C-X-C motif-ligand-12 (CXCL12) cellular, spatial, and temporal expression. We found that the fracture repair process elicited an early site-specific response of CXCL12+-BMP2+ endosteal cells and osteocytes that was not present in unfractured bones and gradually decreased as healing progressed. Absence of a full complement of BMP2 in mesenchyme osteoprogenitors (BMP2cKO/+) prevented healing and led to a dysregulated temporal and cellular upregulation of CXCL12 expression associated with a deranged angiogenic response. Healing was rescued when BMP2cKO/+ mice were systemically treated with AMD3100, an antagonist of CXCR4 and agonist for CXCR7 both receptors for CXCL12. We further found that mesenchymal stromal cells (MSCs), capable of delivering BMP2 at the endosteal site, restored fracture healing when transplanted into BMP2cKO/+ mice by rectifying the CXCL12 expression pattern. Our in vitro studies showed that in isolated endosteal cells, BMP2, while inducing osteoblastic differentiation, stimulated expression of pericyte markers that was coupled with a decrease in CXCL12. Furthermore, in isolated BMP2cKO/cKO endosteal cells, high expression levels of CXCL12 inhibited osteoblastic differentiation that was restored by AMD3100 treatment or coculture with BMP2-expressing MSCs that led to an upregulation of pericyte markers while decreasing platelet endothelial cell adhesion molecule (PECAM). Taken together, our studies show that following fracture, a CXCL12+-BMP2+ perivascular cell population is recruited along the endosteum, then a timely increase of BMP2 leads to downregulation of CXCL12 that is essential to determine the fate of the CXCL12+-BMP2+ to osteogenesis while departing their supportive role to angiogenesis. Our findings have far-reaching implications for understanding mechanisms regulating the selective recruitment of distinct cells into the repairing niches and the development of novel pharmacological (by targeting BMP2/CXCL12) and cellular (MSCs, endosteal cells) interventions to promote fracture healing.",
keywords = "BMP2, CXCL12, ENDOSTEAL CELLS, FRACTURE REPAIR, MESENCHYMAL STROMAL CELLS",
author = "Myers, {Timothy J.} and Lara Longobardi and Helen Willcockson and Temple, {Joseph D.} and Lidia Tagliafierro and Ping Ye and Tieshi Li and Alessandra Esposito and Moats-Staats, {Billie M.} and Anna Spagnoli",
year = "2015",
month = "11",
doi = "10.1002/jbmr.2548",
language = "English (US)",
volume = "30",
pages = "2014--2027",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - BMP2 Regulation of CXCL12 Cellular, Temporal, and Spatial Expression is Essential during Fracture Repair

AU - Myers, Timothy J.

AU - Longobardi, Lara

AU - Willcockson, Helen

AU - Temple, Joseph D.

AU - Tagliafierro, Lidia

AU - Ye, Ping

AU - Li, Tieshi

AU - Esposito, Alessandra

AU - Moats-Staats, Billie M.

AU - Spagnoli, Anna

PY - 2015/11

Y1 - 2015/11

N2 - The cellular and humoral responses that orchestrate fracture healing are still elusive. Here we report that bone morphogenic protein 2 (BMP2)-dependent fracture healing occurs through a tight control of chemokine C-X-C motif-ligand-12 (CXCL12) cellular, spatial, and temporal expression. We found that the fracture repair process elicited an early site-specific response of CXCL12+-BMP2+ endosteal cells and osteocytes that was not present in unfractured bones and gradually decreased as healing progressed. Absence of a full complement of BMP2 in mesenchyme osteoprogenitors (BMP2cKO/+) prevented healing and led to a dysregulated temporal and cellular upregulation of CXCL12 expression associated with a deranged angiogenic response. Healing was rescued when BMP2cKO/+ mice were systemically treated with AMD3100, an antagonist of CXCR4 and agonist for CXCR7 both receptors for CXCL12. We further found that mesenchymal stromal cells (MSCs), capable of delivering BMP2 at the endosteal site, restored fracture healing when transplanted into BMP2cKO/+ mice by rectifying the CXCL12 expression pattern. Our in vitro studies showed that in isolated endosteal cells, BMP2, while inducing osteoblastic differentiation, stimulated expression of pericyte markers that was coupled with a decrease in CXCL12. Furthermore, in isolated BMP2cKO/cKO endosteal cells, high expression levels of CXCL12 inhibited osteoblastic differentiation that was restored by AMD3100 treatment or coculture with BMP2-expressing MSCs that led to an upregulation of pericyte markers while decreasing platelet endothelial cell adhesion molecule (PECAM). Taken together, our studies show that following fracture, a CXCL12+-BMP2+ perivascular cell population is recruited along the endosteum, then a timely increase of BMP2 leads to downregulation of CXCL12 that is essential to determine the fate of the CXCL12+-BMP2+ to osteogenesis while departing their supportive role to angiogenesis. Our findings have far-reaching implications for understanding mechanisms regulating the selective recruitment of distinct cells into the repairing niches and the development of novel pharmacological (by targeting BMP2/CXCL12) and cellular (MSCs, endosteal cells) interventions to promote fracture healing.

AB - The cellular and humoral responses that orchestrate fracture healing are still elusive. Here we report that bone morphogenic protein 2 (BMP2)-dependent fracture healing occurs through a tight control of chemokine C-X-C motif-ligand-12 (CXCL12) cellular, spatial, and temporal expression. We found that the fracture repair process elicited an early site-specific response of CXCL12+-BMP2+ endosteal cells and osteocytes that was not present in unfractured bones and gradually decreased as healing progressed. Absence of a full complement of BMP2 in mesenchyme osteoprogenitors (BMP2cKO/+) prevented healing and led to a dysregulated temporal and cellular upregulation of CXCL12 expression associated with a deranged angiogenic response. Healing was rescued when BMP2cKO/+ mice were systemically treated with AMD3100, an antagonist of CXCR4 and agonist for CXCR7 both receptors for CXCL12. We further found that mesenchymal stromal cells (MSCs), capable of delivering BMP2 at the endosteal site, restored fracture healing when transplanted into BMP2cKO/+ mice by rectifying the CXCL12 expression pattern. Our in vitro studies showed that in isolated endosteal cells, BMP2, while inducing osteoblastic differentiation, stimulated expression of pericyte markers that was coupled with a decrease in CXCL12. Furthermore, in isolated BMP2cKO/cKO endosteal cells, high expression levels of CXCL12 inhibited osteoblastic differentiation that was restored by AMD3100 treatment or coculture with BMP2-expressing MSCs that led to an upregulation of pericyte markers while decreasing platelet endothelial cell adhesion molecule (PECAM). Taken together, our studies show that following fracture, a CXCL12+-BMP2+ perivascular cell population is recruited along the endosteum, then a timely increase of BMP2 leads to downregulation of CXCL12 that is essential to determine the fate of the CXCL12+-BMP2+ to osteogenesis while departing their supportive role to angiogenesis. Our findings have far-reaching implications for understanding mechanisms regulating the selective recruitment of distinct cells into the repairing niches and the development of novel pharmacological (by targeting BMP2/CXCL12) and cellular (MSCs, endosteal cells) interventions to promote fracture healing.

KW - BMP2

KW - CXCL12

KW - ENDOSTEAL CELLS

KW - FRACTURE REPAIR

KW - MESENCHYMAL STROMAL CELLS

UR - http://www.scopus.com/inward/record.url?scp=84944731593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944731593&partnerID=8YFLogxK

U2 - 10.1002/jbmr.2548

DO - 10.1002/jbmr.2548

M3 - Article

C2 - 25967044

AN - SCOPUS:84944731593

VL - 30

SP - 2014

EP - 2027

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 11

ER -